Syncona Limited NPV (SYNC)

Sector:

Investment Firms

Index:

FTSE 250

80.00p
   
  • Change Today:
    -4.00p
  • 52 Week High: 125.80
  • 52 Week Low: 80.00
  • Currency: UK Pounds
  • Shares Issued: 609.59m
  • Volume: 890,719
  • Market Cap: £487.68m
  • RiskGrade: 291
  • Beta: 0.01

Syncona investment sells cancer study assets to AstraZeneca for $12m

By Frank Prenesti

Date: Friday 27 Dec 2024

LONDON (ShareCast) - (Sharecast News) - Life science investor Syncona said its investment Achilles Therapeutics has sold cancer study assets to AstraZeneca for $12m (£9.58m).
The deal involves transferring of the commercial license of data and samples from Achilles' TRACERx non-small cell lung cancer study to AstraZeneca, including samples and data.

Achilles added that it intended to cut an unspecified number of jobs and reduce the size of its board of directors.

Completion of this transaction signals the conclusion of the strategic review which was announced in September 2024.

Reporting by Frank Prenesti for Sharecast.com







Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SYNC Market Data

Currency UK Pounds
Share Price 80.00p
Change Today -4.00p
% Change -4.76 %
52 Week High 125.80
52 Week Low 80.00
Volume 890,719
Shares Issued 609.59m
Market Cap £487.68m
Beta 0.01
RiskGrade 291

SYNC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
62.01% above the sector average62.01% above the sector average62.01% above the sector average62.01% above the sector average62.01% above the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
93.42% below the sector average93.42% below the sector average93.42% below the sector average93.42% below the sector average93.42% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
87.68% above the sector average87.68% above the sector average87.68% above the sector average87.68% above the sector average87.68% above the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SYNC Dividends

  Latest Previous
  Final Final
Ex-Div 21-Jun-18 20-Jul-17
Paid 30-Jul-18 23-Aug-17
Amount 2.30p 2.30p

Trades for 30-May-2025

Time Volume / Share Price
16:35 221,569 @ 80.00p
16:35 399 @ 80.00p
16:35 1,866 @ 80.00p
16:35 592 @ 80.00p
16:35 10,000 @ 80.00p

SYNC Key Personnel

Chair Melanie Gee

Top of Page